Efficacy and safety of sucroferric oxyhydroxide in the treatment of hyperphosphataemia in chronic kidney disease in Asturias. FOSFASTUR study J. Emilio Sanchez-Alvarez; Elena Astudillo Cortés; Miguel Seras Mozas; Raúl García Castro; Carlos Miguel Hidalgo Ordoñez; Ana Cristina Andrade López; Catalina Ulloa Clavijo; Anna Gallardo Pérez; Carmen Rodríguez Suarez;

Effectivity and safety profile of tenapanor, a sodium-hydrogen exchanger isoform 3 inhibitor, as an innovative treatment for hyperphosphatemia in chronic kidney disease: A systematic review of clinical studies William Suciangto; Haerani Rasyid; Anastasya Angelica Vicente; Winny Suciangto;

Definition and evolution of the concept of sarcopenia Maria Luz Sanchez-Tocino; Secundino Cigarrán; Pablo Ureña; Maria Luisa González-Casaus; Sebastian Mas-Fontao; Carolina Gracia-Iguacel; Alberto Ortíz; Emilio Gonzalez-Parra;